Myeloma patients had a significantly lower precursor frequency of survivin reactive CD4+CD25- cells (range 0% to 2.2x10-3%) compared to healthy donors (range 1.1x10-3 to 8.4x10-3%) (Figure 3A). The gene discussed is BIRC5; the disease is plasma cell myeloma.